Retatrutide 20mg is a next-generation investigational peptide designed as a triple agonist of GLP-1, GIP, and glucagon receptors. With its advanced profile, Retatrutide is being studied for potential applications in glucose regulation, lipid metabolism, energy expenditure, and weight management. Researchers value its ability to explore broader metabolic mechanisms compared to single or dual agonists. Available in the UK, Retatrutide is offered with high-quality standards for reliable results in scientific research. For laboratory and investigational use only.

Important Information

This product is intended for laboratory research use only.

• Not for human consumption.
• Not for veterinary or medical use.
• For qualified research professionals only.